Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Taiwan Fines coming into force for selling or using e-cigs…
  • United Kingdom ‘Smokefree 2030’ – government promises proposals soon…
  • United States Schumer tells FDA to take strong action against ‘kid-friendly’ Elf Bar…
  • Belgium E-cigarette notification lists updated…
  • United Kingdom Counterfeit e-cigs seized…
  • Italy Ministers plan new administrative procedures for e-cig sales network…
  • Egypt Customs clarifies e-cig tax rates…
  • Bahrain Health ministry oversight extended for nicotine product standards…
  • Bulgaria Finance ministry introduces draft law increasing e-cig taxes…
  • Europe EU member states want more flexible packaging law…
  • Netherlands Inspection finds many stores violate display ban…
  • United States FDA issues MDOs for two menthol Vuse products…
View all
News analysis

Label changes do not require FDA approval, DC court rules

Written by || 22nd August 2016 || News analysis || Regulation and Legislation | District of Columbia North America United States

Tobacco companies will be able to amend product labels without having to go through a federal review process, following a mixed victory by the industry in court. ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Challenging the U.S. deeming rule: the legal options and their chances
Deeming regs: challenges to the sampling ban
Defusing the deeming regs: Congress, courts, and the FDA